184 related articles for article (PubMed ID: 31254616)
1. Intraosteoblastic activity of levofloxacin and rifampin alone and in combination against clinical isolates of meticillin-susceptible Staphylococcus aureus causing prosthetic joint infection.
Meléndez-Carmona MÁ; Muñoz-Gallego I; Viedma E; Lora-Tamayo J; Chaves F
Int J Antimicrob Agents; 2019 Sep; 54(3):356-360. PubMed ID: 31254616
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial activity against intraosteoblastic Staphylococcus aureus.
Valour F; Trouillet-Assant S; Riffard N; Tasse J; Flammier S; Rasigade JP; Chidiac C; Vandenesch F; Ferry T; Laurent F
Antimicrob Agents Chemother; 2015 Apr; 59(4):2029-36. PubMed ID: 25605365
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal activity of the combination of levofloxacin with rifampin in experimental prosthetic knee infection in rabbits due to methicillin-susceptible Staphylococcus aureus.
Muller-Serieys C; Saleh Mghir A; Massias L; Fantin B
Antimicrob Agents Chemother; 2009 May; 53(5):2145-8. PubMed ID: 19273687
[TBL] [Abstract][Full Text] [Related]
4. Moxifloxacin plus rifampin as an alternative for levofloxacin plus rifampin in the treatment of a prosthetic joint infection with Staphylococcus aureus.
Wouthuyzen-Bakker M; Tornero E; Morata L; Nannan Panday PV; Jutte PC; Bori G; Kampinga GA; Soriano A
Int J Antimicrob Agents; 2018 Jan; 51(1):38-42. PubMed ID: 28668678
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of oritavancin in combination with rifampin or gentamicin against prosthetic joint infection-associated methicillin-resistant Staphylococcus epidermidis biofilms.
Yan Q; Karau MJ; Raval YS; Patel R
Int J Antimicrob Agents; 2018 Nov; 52(5):608-615. PubMed ID: 30048689
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of Staphylococcus aureus and Staphylococcus epidermidis isolated from prosthetic joint infections.
Molina-Manso D; del Prado G; Ortiz-Pérez A; Manrubia-Cobo M; Gómez-Barrena E; Cordero-Ampuero J; Esteban J
J Antibiot (Tokyo); 2012 Oct; 65(10):505-8. PubMed ID: 22854340
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of antibiotic treatment of implant-associated
Greimel F; Scheuerer C; Gessner A; Simon M; Kalteis T; Grifka J; Benditz A; Springorum HR; Schaumburger J
Drug Des Devel Ther; 2017; 11():1729-1736. PubMed ID: 28652709
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a novel rifamycin derivative, ABI-0043, against Staphylococcus aureus in an experimental model of foreign-body infection.
Trampuz A; Murphy CK; Rothstein DM; Widmer AF; Landmann R; Zimmerli W
Antimicrob Agents Chemother; 2007 Jul; 51(7):2540-5. PubMed ID: 17502404
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of novel anti-MRSA cephalosporins and comparator antimicrobial agents against staphylococci involved in prosthetic joint infections.
Isnard C; Dhalluin A; Malandain D; Bruey Q; Auzou M; Michon J; Giard JC; Guérin F; Cattoir V
J Glob Antimicrob Resist; 2018 Jun; 13():221-225. PubMed ID: 29421316
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.
Murillo O; Doménech A; Garcia A; Tubau F; Cabellos C; Gudiol F; Ariza J
Antimicrob Agents Chemother; 2006 Dec; 50(12):4011-7. PubMed ID: 17015630
[TBL] [Abstract][Full Text] [Related]
11. Strain-to-strain variability among Staphylococcus aureus causing prosthetic joint infection drives heterogeneity in response to levofloxacin and rifampicin.
Meléndez-Carmona MÁ; Mancheño-Losa M; Ruiz-Sorribas A; Muñoz-Gallego I; Viedma E; Chaves F; Van Bambeke F; Lora-Tamayo J
J Antimicrob Chemother; 2022 Nov; 77(12):3265-3269. PubMed ID: 36124848
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic evaluation of the activity of antibiotics against hemin- and menadione-dependent small-colony variants of Staphylococcus aureus in models of extracellular (broth) and intracellular (THP-1 monocytes) infections.
Garcia LG; Lemaire S; Kahl BC; Becker K; Proctor RA; Denis O; Tulkens PM; Van Bambeke F
Antimicrob Agents Chemother; 2012 Jul; 56(7):3700-11. PubMed ID: 22564838
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of linezolid or trimethoprim/sulfamethoxazole in combination with rifampicin as alternative oral treatments based on an in vitro pharmacodynamic model of staphylococcal biofilm.
El Haj C; Murillo O; Ribera A; Lloberas N; Gómez-Junyent J; Tubau F; Fontova P; Cabellos C; Ariza J
Int J Antimicrob Agents; 2018 Jun; 51(6):854-861. PubMed ID: 29374577
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility and biofilm formation of Staphylococcus epidermidis small colony variants associated with prosthetic joint infection.
Maduka-Ezeh AN; Greenwood-Quaintance KE; Karau MJ; Berbari EF; Osmon DR; Hanssen AD; Steckelberg JM; Patel R
Diagn Microbiol Infect Dis; 2012 Nov; 74(3):224-9. PubMed ID: 22901790
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics of once- or twice-daily levofloxacin versus vancomycin, with or without rifampin, against Staphylococcus aureus in an in vitro model with infected platelet-fibrin clots.
Palmer SM; Rybak MJ
Antimicrob Agents Chemother; 1996 Mar; 40(3):701-5. PubMed ID: 8851596
[TBL] [Abstract][Full Text] [Related]
16. Extracellular and intracellular bactericidal activities of XF-70 against small-colony variant hemB mutants of meticillin-susceptible and meticillin-resistant Staphylococcus aureus.
Vaudaux P; Huggler E; Rhys-Williams W; Love WG; Lew DP
Int J Antimicrob Agents; 2011 Jun; 37(6):576-9. PubMed ID: 21414759
[TBL] [Abstract][Full Text] [Related]
17. [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].
Soriano A; Jurado A; Marco F; Almela M; Ortega M; Mensa J
Rev Esp Quimioter; 2005 Jun; 18(2):168-72. PubMed ID: 16130039
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the ability of linezolid and tedizolid to eradicate intraosteoblastic and biofilm-embedded Staphylococcus aureus in the bone and joint infection setting.
Abad L; Tafani V; Tasse J; Josse J; Chidiac C; Lustig S; Ferry T; Diot A; Laurent F; Valour F
J Antimicrob Chemother; 2019 Mar; 74(3):625-632. PubMed ID: 30517641
[TBL] [Abstract][Full Text] [Related]
19. Antagonistic effect of rifampin on the efficacy of high-dose levofloxacin in staphylococcal experimental foreign-body infection.
Murillo O; Pachón ME; Euba G; Verdaguer R; Tubau F; Cabellos C; Cabo J; Gudiol F; Ariza J
Antimicrob Agents Chemother; 2008 Oct; 52(10):3681-6. PubMed ID: 18676888
[TBL] [Abstract][Full Text] [Related]
20. Lysosomal alkalization to potentiate eradication of intra-osteoblastic Staphylococcus aureus in the bone and joint infection setting.
Abad L; Chauvelot P; Audoux E; Andre C; Josse J; Dupieux C; Lustig S; Ferry T; Verhoeven PO; Diot A; Laurent F; Valour F
Clin Microbiol Infect; 2022 Jan; 28(1):135.e1-135.e7. PubMed ID: 33962064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
